Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
1/21/2010 Goals of this presentation Clinical Trials: Adverse Events, Toxicity Criteria & Reporting, and Managing Symptoms Willis Navarro, MD Medical Director, Transplant Services National Marrow Donor Program Form 2100 • Questions 497-528 • Review the “Other Organ Impairment/ Disorder” section of Form 2100 • Review AEs, “incidents” associated with stem cell infusion on Form 2006 • Discuss the context of each item in the marrow transplant realm • Review the management of the symptoms/complications • Liver, lung AEs not covered because of previous presentations Avascular Necrosis • Synonyms: osteonecrosis, bone necrosis, ischemic bone necrosis • Pathophysiology: Results from ischemia of the end of the bone (usually femur at the hip hip, but also the knee, shoulder joints) • Risks: Underlying risk is often steroid use, but includes alcoholism, vasculitis, radiation injury, hemoglobinopathies (sickle cell, etc) • Symptoms include pain, decreased range of motion of the affected joint Avascular Necrosis Cataracts • DDx: osteomyelitis, fracture due to osteoporosis • Diagnosis: radiographic QuickTime™ and a decompressor are needed to see this picture. • Treatment: • Synonyms: traumatic cataract (the trauma is usually radiation or drug effect in the case of HCT) • Pathophysiology: Results most likely from oxidative stress to the lens with age, but accelerated especially by radiation injury; proteins become opaque, water content falls • Risks: Underlying risk is often radiation injury but also includes steroid use, possibly alcohol, smoking, age, diabetes, • Symptoms include decreased visual acuity, glare – symptomatic treatment – decreased weight bearing – joint replacement 1 1/21/2010 Cataracts Congestive Heart Failure • DDx: eye injury, other eye problems • Diagnosis: physical exam (slit lamp) • Treatment/Management: – Observation/monitoring – Surgical lens extraction QuickTime™ and a decompressor are needed to see this picture. • Intracapsular cataract extraction (ICCE) • Extracapsular cataract extraction (ECCE) • Phacoemulsification Congestive Heart Failure • • • DDx: volume overload, sepsis, “diastolic” dysfunction, Diagnosis: echocardiography, increased b-natriuretic protein ((BNP), ), CXR,, physical p y exam,, MUGA scan, cardiac catheterization Treatment/Management: Diabetes Mellitus/Hyperglycemia • Caveat (again): discussion here will be limited in scope to transplant-associated issues or we would be here for hours… • Synonyms: none, really • Pathophysiology: where do I begin? Diabetes is a syndrome of either decreased insulin production (Type 1-often 1 often autoimmune) or insulin resistance (Type 2, “adult onset”), often with endorgan damage as a result of long-standing hyperglycemia. Hyperglycemia is simply blood glucose above the upper limit of normal (and isn’t necessarily diabetes). • Risks: pregnancy, steroids, certain chemo drugs (but ones not used in transplant), sepsis (for hyperglycemia) • Signs and Symptoms include increased serum glucose, elevated Hgb A1C, end organ damage-related (peripheral neuropathy, renal failure, CVD, PVD) QuickTime™ and a decompressor are needed to see this picture. – Diuretics, ACE inhibitors, vasodilators – Correct underlying issue (stop EtOH, fix valve, etc) – Inotropic agents, beta blockers – Heart transplant Diabetes Mellitus/Hyperglycemia • DDx: glucose intolerance • Diagnosis: serum glucose, microalbuminuria, elevated Hgb A1C • Treatment/Management: T t t/M t QuickTime™ and a decompressor are needed to see this picture. – – – – • Caveat: discussion here will be limited in scope to transplantassociated issues or we would be here for hours… • Synonyms: left-sided heart failure, left ventricular systolic dysfunction, CHF • Pathophysiology: where do I begin? Anything that affects the function of myocytes directly (toxins, Chagas’, inherited syndromes), or which causes a persistent excessive load on the heart(MI, HTN, valvular disorders); note that CHF is the result of a pathologic process in the circulatory system • Risks: certain chemotherapeutics (anthracyclines in particular), myocardial infarction, inherited disorders, long-standing hypertension, alcoholism, valvular disorders; rarely, infections like Chagas’; certain viral infections (Coxsackie, etc) • Signs and Symptoms include poor exercise tolerance, rales, dyspnea, pleural effusions, pulmonary edema, lower extremity edema, cardiac dysrhythmias (especially a fib); cardiomegaly Anti-hyperglycemics, insulin Treat underlying cause of hyperglycemia Weight loss, exercise Pancreas transplant for Type I in some cases Gonadal Dysfunction Requiring Hormone Replacement/Infertility • Note that I changed the “requiring hormone replacement” to associate with gonadal dysfunction, though Form 2100 has in the opposite order • Synonyms: hypogonadism, sterility, early menopause, yp , hypoestrogenism yp g hypotestosteronism, • Pathophysiology: damage from chemotherapy and/or radiation can lead to gonadal failure; more likely to occur in women, increased risk with age; prepubescent children will manifest delayed or arrested sexual development; indirect failure can result from primary pituitary failure • Risks: radiotherapy; alkylating chemo agents (cyclophosphamide, busulfan, BCNU, CCNU, melphalan, nitrogen mustard, and many others) • Signs and Symptoms include low measured testosterone or estrogen levels, menopause symptoms, decreased libido, impotence, dysparuria, muscle wasting in men 2 1/21/2010 Gonadal Dysfunction Requiring Hormone Replacement/Infertility Growth Hormone Deficiency/Growth Disturbance • DDx: hormone replacement for reasons other than gonadal failure (i.e. testosterone for muscle wasting, or for red cell production); infertility of the partner of the patient • Diagnosis: symptoms consistent with decreased sex hormone levels, confirmation by estrogen or testosterone levels (caution: hormone levels must be interpreted in context) • Treatment/Management: • Synonyms/Related Disorders: panhypopituitarism, short stature, psychosocial dwarfism, achondroplasia, Noonan syndrome, hypothyroidism, constitutional growth delay • CAVEAT: keep in mind that reporting is required only for those p p issues which occurred “after the start of the preparative regimen” so one issue in this category is to sort out any growth issue that was ongoing prior to transplant (growth disturbance) • Pathophysiology: Growth hormone (GH) production is stimulated by GHRH; pituitary damage (radiation, tumor, surgery), or congenital defects can impair GH production; damage to the hypothalamus can prevent adequate GHRH production • Risks: radiotherapy, especially to the CNS as with ALL therapy; • Signs and Symptoms include short stature but normal appearance/proportions – Hormone replacement therapy – Infertility care (hormones, in vitro fertilization, surrogacy) Growth Hormone Deficiency/Growth Disturbance Hemorrhagic Cystitis/Hematuria Requiring Medical Intervention • DDx: short stature but normal variant, other inherited disorders of growth (IGF-1 insensitivity, Prader-Willi and Noonan syndromes, etc) • Diagnosis: evaluation of levels of IGF-1, IGFBP-3 (GH dependent); karyotype; TFTs, MRI; GH is tough to measure (must be stimulated) • Treatment/Management: • Synonyms: blood in urine • Pathophysiology: injury to bladder epithelium, usually by radiation or the chemo drugs cyclophosphamide or ifosphamide, or due to viral infections, esp. BK virus but also CMV, adenovirus; may also be related to trauma (urinary catheters), or • Risks: as above; infectious causes enhanced in HCT settings with slow immune recovery • Signs and Symptoms include hematuria, sometimes with significant bleeding, urinary obstruction due to gross clotting is seen – Growth hormone replacement – Monitoring for failure of other pituitary hormones (thyroid, sex hormones) axis QuickTime™ and a decompressor are needed to see this picture. Hemorrhagic Cystitis/Hematuria Requiring Medical Intervention • DDx: bleeding from another site (vaginal in women) • Diagnosis: urinalysis, cystoscopy • Treatment/Management: – – – – – Transfusion support Bladder irrigation Urology consult Cytoscopic fulguration of bleeding areas Surgery QuickTime™ and a decompressor are needed to see this picture. Hypothyroidism • Synonyms: none • Pathophysiology: Usually due to primary thyroid failure due to toxic effects of chemo and/or radiation or but can be secondary due to failure of TSH secretion • Risks: chemotherapy and/or radiation, autoimmunity, effects of GVHD • Signs and Symptoms include fatigue, weight gain, cold intolerance, but also many other non-specific symptoms 3 1/21/2010 Hypothyroidism Myocardial Infarction • DDx: lots of symptoms of hypothyroidism can be attributed to other disorders • Diagnosis: elevated TSH (primary thyroid failure) or low TSH with low T3 and T4 hormone levels • Treatment/Management: • Synonyms: heart attack, • Pathophysiology: severe and persistent ischemia to the cardiac muscle leads to myocyte cell death and then scarring with repair • Risks: atherosclerosis, history of radiotherapy including the heart in the treatment window, cardiac risk factors • Signs and Symptoms include chest pain, nausea, fatigue, dyspnea, sudden death – Replacement QuickTime™ and a decompressor are needed to see this picture. QuickTime™ and a decompressor are needed to see this picture. Myocardial Infarction • DDx: aortic dissection, GERD, pericarditis, esophagitis/esophageal spasm, pneumothorax • Diagnosis: increased troponin, CPK-MB fraction, EKG with characteristic changes, echocardiography showing focal wall motion abnormalities, cardiac catheterization • Treatment/Management: – Vessel unblocking (via stent/angioplasty, coronary artery bypass) – Beta blockers, nitrates, ASA, antiplatelet agents, ACEI – Risk factor reduction maneuvers Pancreatitis QuickTime™ and a decompressor are needed to see this picture. • Synonyms: none • Pathophysiology: problem with the control mechanisms that keep pancreatic enzymes under control, usually associated with pancreatic cellular injury (toxins like EtOH, chemo drugs, radiation); gallstone blockage of duct is most common cause; in heme malig setting: L-asparaginase, GVHD • Risks: as above • Signs and Symptoms include fever, tachycardia, abdominal pain, less commonly jaundice Pancreatitis TTP/HUS • DDx: gall bladder disease, pancreatic cancer, myocardial infarction, pneumonia • Diagnosis: amylase, lipase serum levels, abdominal imaging • Treatment/Management: • Synonyms: none • Pathophysiology: the lack of the enzyme required to break down large multimers of vWF leads to TTP; fibrin microvascular clots develop and shear RBCs; renal failure, CNS symptoms result. Can be autoimmune or drug-based • Risks: calcineurin inhibitors, exposure to O157:H7 E. Coli, other drugs • Signs and Symptoms include thrombocytopenia, schistocytes on the peripheral smear, renal failure, fever, CNS symptoms, elevated LDH – – – – Bowel rest Pain medications Fluid support Surgical intervention if there is a mechanical issue that can be dealt with QuickTime™ and a decompressor are needed to see this picture. 4 1/21/2010 TTP/HUS Renal Failure Warranting Dialysis • DDx: DIC, malignant hypertension • Diagnosis: having the pentad (required: increased LDH, schistocytes; often seen: fever renal and CNS manifestations); should fever, have a negative w/u for DIC • Treatment/Management: – Plasma exchange – Stop offending drug – Rituximab for autoimmune form • Synonyms: kidney failure, ESRD, ARF, acute tubular necrosis (ATN), azotemia • Pathophysiology: often multifactorial but associated with nephrotoxic drugs, particularly calcineurin inhibitors, some g antibiotics,, cidofovir,, manyy others;; severe stressors during transplant (sepsis) can lead to temporary renal failure requiring dialysis or hemofiltration (usually done in the ICU; continuous so reduced fluid shifts, but equivalent to dialysis) • Risks: multiple • Signs and Symptoms include uremic symptoms (confusion, nausea and vomiting, tremor, coma), reduced or absent urine output Renal Failure Warranting Dialysis • DDx: pre-renal vs infrarenal vs post-renal causes • Diagnosis: abnl urinalysis, rapidly rising creatinine calcium and acid creatinine, acid-base base disturbances, symptoms of uremia, anemia if chronic • Treatment/Management: – Dialysis or hemofiltration – Supportive measures, reduce/eliminate nephrotoxic drugs QuickTime™ and a decompressor are needed to see this picture. Stroke/Seizure Stroke/Seizure • Synonyms: – Stroke: CVA, brain ischemia – Seizure: epilepsy • Pathophysiology: – Stroke: due to embolic or thrombotic clot, clot ischemia, ischemia and loss of function. Because of neuronal crossover, loss is on the opposite side from the stroke; handedness matters for speech centers – Seizure: due to uncontrolled electrical activity • Risks: stroke: similar to MI risk factors; seizure: prior head injury, some medications, brain tumor, inherited disorders • Signs and Symptoms – Stroke: hemiplegia, visual disturbance, dizziness, headache, balance disturbance – Seizure: physical exam, post-ictal state Form 2100: Other Adverse Events QuickTime™ and a decompressor are needed to see this picture. • DDx: – Stroke: CNS hemorrhage; seizure; migraine, TIA (stroke-like but temporary); CNS infection – Seizure: • Diagnosis: Di i – Stroke: physical exam, brain MRI (more sensitive early on); head CT – Seizure: physical exam, EEG • Treatment/Management: – Stroke: thrombolytics, ASA, control hypertension if present – Seizure: antiseizure drugs (lots of different drugs) • Report events that were serious – – – – – – Life-threatening Led to initial or prolonged hospitalization Resulted in death Resulted in a birth defect Resulted in disability Required medical intervention to prevent permanent impairment or damage 5 1/21/2010 The Problems with Question 528: “Other” • Stuff here that should go elsewhere – PTLD (Question 549-lymphoma or lymphoproliferative disease) – Seizures (Q (Q. 524-stroke/seizures) 524 stroke/seizures) – Low testosterone (Q. 506-gonadal dysfxn) – Elevated LFTs (Q. 490-elevated liver enzymes) – BK virus cystitis, typhilitis, gangrenous gallbladder (Q. 389-site and infectious agent) The Problems with Question 528: “Other” • Examples of items not covered elsewhere that do go here: – – – – – – – – The Problems with Question 528: “Other” • Stuff that doesn’t fit “any clinically significant organ impairment or disorder after the start of the prep regimen to last contact” – – – – white discoloration of tongue (too vague) redman syndrome (not clinically significant) occasional dysuria (not clinically significant) leukemia cutis (relapse or secondary malig, not an organ impairment) – osteoporosis (almost certainly pre-existing give the 100 day timeframe) – death (not an organ impairment, report elsewhere) – renal failure (if not requiring dialysis, not significant) Form 2006: InfusionAssociated AEs/Incidents • Questions 202-263 DVT Steroid myopathy DIC CNS hemorrhage Hearing loss TRALI Leukoencephalopathy Etc… Terms • Bradycardia: simply defined as a measured heart rate less than 60 bpm • Chest tightness/pain • Chill att titime off iinfusion f i • Fever ≤103°F or >103°F (39.4°C) within 24 hrs of infusion • Gross hemoglobinuria: as opposed to microscopic; urine should have been visibly pink to red; gross hematuria is equivalent More Terms • Headache: as reported and documented • Hives: may also be reported as urticaria or wheal and flare reaction • Hypertension: H t i SBP≥140 or DBP≥90 • Hypotension: SBP<90 and/or DBP<60 (but this is sketchier) • Hypoxia requiring O2 support (nl O2 saturation can vary even with altitude) • Nausea: as reported and documented 6 1/21/2010 Even More Terms • Rigors, Mild: resolving without pharmacologic intervention • Rigors, Severe: requiring pharmacologic treatment • Shortness of breath (dyspnea): as reported and documented • Tachycardia: heart rate >100 bpm • Vomiting Other Expected AEs • Infusional reactions related to DMSO – Abdominal pain/cramping – Flushing – Cough – Malaise Questions? 7